Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 146 | 2 | 159 | +15 |
| Shares | 36.9M | 885.9K | 48.9M | +12.9M (+35.7%) |
| Value | $955.6M | $22.9M | $1.55B | +$613.0M (+65.7%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (17)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $41.9M |
| Point72 Asset Management, L.P. | 601,038 | $15.5M |
| Wasatch Advisors Inc | 230,461 | $5.96M |
| Qube Research & Technologies Ltd | 39,891 | $1.03M |
| Adams Street Partners LLC | 29,849 | $772.2K |
| Algert Global LLC | 25,940 | $671.1K |
| Pathway Capital Management, LP | 24,784 | $641.2K |
| Utah Retirement Systems | 17,909 | $463.3K |
| Centiva Capital, LP | 12,535 | $324.3K |
| Genworth Financial Inc | 11,939 | $308.9K |
| Alberta Investment Management Corp | 10,310 | $266.7K |
| Dynamic Technology Lab Private Ltd | 9,350 | $242.0K |
| Denali Advisors LLC | 6,800 | $175.9K |
| StepStone Group LP | 4,179 | $108.1K |
| Simplex Trading, LLC | 1,674 | $43.0K |
| Northwestern Mutual Wealth Management Co | 785 | $20.3K |
| CWM, LLC | 199 | $5.00K |
Not filed for Q3 2023 yet (2)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 883,979 | $22.9M |
| Endurance Wealth Management, Inc. | 1,954 | $50.0K |